Pricing Log in Create free account

Denali Therapeutics Inc. (DNLI) vs Viking Therapeutics, Inc. (VKTX)

Denali Therapeutics Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. Denali Therapeutics Inc. and Viking Therapeutics, Inc. are of similar size ($3.3B and $3.2B). Viking Therapeutics, Inc. has the higher net margin (0.00% vs −1,388.2%) and the higher return on invested capital (0.00% vs −80.0%). Across the 14 metrics below, Denali Therapeutics Inc. leads on 9 and Viking Therapeutics, Inc. on 5.

Valuation

Metric DNLI VKTX Biotechnology median
P/E n/m n/m 10.26
P/S 165.44 n/m 9.18
P/B 4.04 5.18 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 142.89 n/m 8.98
Earnings yield (8.69%) (20.90%) (34.89%)
Free cash flow yield (12.01%) (15.17%) (24.52%)

Profitability

Metric DNLI VKTX Biotechnology median
Gross margin 98.74% 0.00% 65.16%
Operating margin (2,348.95%) 0.00% 0.00%
Net margin (1,388.24%) 0.00% 0.00%
Free cash flow margin (1,986.81%) 0.00% 0.00%
Return on equity (33.94%) (96.37%) (50.12%)
Return on assets (27.20%) (73.07%) (45.60%)
Return on invested capital (80.00%) 0.00% 0.00%

Growth

Metric DNLI VKTX Biotechnology median
Revenue growth (TTM) (93.40%) — 6.26%
EPS growth (last fiscal year) (15.56%) (215.84%) 29.88%
Revenue growth, 5-year CAGR 20.67% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNLI VKTX Biotechnology median
Debt to equity 0.01 0.43 0.00
Current ratio 6.21 7.27 4.89
Net debt to EBITDA 1.56 1.76 1.01

Dividend

Metric DNLI VKTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DNLI VKTX Biotechnology median
Market cap 3.16b 3.29b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack